We are currently enrolling patients for a Waldenstrom’s macroglobulinemia (WM) Pivotal Trial utilizing CLR 131. Additionally, CLR 131 is being evaluated in a multi cohort CLOVER-1 Phase 2 study in adult B-cell malignancies and the CLOVER-2 Phase 1 study for a variety of pediatric cancers.
Clinical Trials Overview
Clinical trials are a fundamental necessity in the development and advancement of new treatment options for battling cancer, and you may not know it, but you could play an important role. Clinical trials need patients to enroll in them so that they can advance through the processes necessary to potentially get a new treatment to market. Your participation in clinical trials can help create a better treatment landscape for future cancer patients.
To learn more general information about clinical trials, please visit www.cancer.org and find the Clinical Studies section.